Labeler · US market

Primus Pharmaceuticals, Inc.

Primus Pharmaceuticals, Inc. is a US drug labeler with US FDA registrations covering 2 drug concepts (2 currently active) across 4 packages.

ACTIVE — US

openFDA · updated weekly

Labeler codes68040

Active drugs2

Registrations2 active / 2

Packages4

Sole supplier of0 drugs

Portfolio2 drugs · US

Every drug concept this labeler has US registrations for, by package count.

Drug	Type	NDCs	Packages	Status
Clobetasol Propionate cream	rx	1	2	SUPPLYING
Betamethasone Dipropionate spray	rx	1	2	SUPPLYING

At a glance

TypeLabeler
Labeler codes68040
Filing names1
Drugs (active)2
Drugs (all time)2
US registrations2
Packages4

Recent events

Shortages, recalls, and registration changes across all filing names.

Jan 26, 2018
RECALLRecall (Class I): Limbrel (flavocoxid 500 mg) capsules, 60-count bottle, Rx only, Manufactured for: Primus Pharmaceuticals, Inc., Scottsd…
Jan 26, 2018
RECALLRecall (Class I): Limbrel500 (flavocoxid and citrated zinc bisglycinate) 500 mg/50 mg capsules, 60-count bottle, Rx only, Manufactured fo…
Jan 26, 2018
RECALLRecall (Class I): Limbrel (flavocoxid 250 mg) capsules, 60-count bottle, Rx only, Manufactured for: Primus Pharmaceuticals, Inc., Scottsd…
Jan 26, 2018
RECALLRecall (Class I): Limbrel250 (flavocoxid and citrated zinc bisglycinate) 250 mg/50 mg capsules, 60-count bottle, Rx only, Manufactured f…

Watch this company

Alerts for recalls, exits, and new registrations.

Facility locations, FDA inspections, and parent-company mapping are on the roadmap. Name variants reported to FDA under different spellings are merged into this profile; figures cover the entity across all its filing names.